Indeed, treatment of NSCLC cells with harmine, a DYRK1A inhibitor, resulted in induction of apoptosis and suppression of cell proliferation following Bcl-2 inhibitor treatment. The gene discussed is DYRK1A; the disease is non-small cell lung carcinoma.